Histogenics Corp (HSGX) - Medical Equipment - Deals and Alliances Profile

Region:North America

Author(s):

Product Code:GDME6500D

Download Sample Report download
Buy the Full ReportStarting from $250
Published on

October 2018

Total pages

45

Table of Content

Download Sample Report download
Buy the Full ReportStarting from $250

About the Report

About the Report

Summary

Histogenics Corp (Histogenics) is a regenerative medicine company that develops, markets and commercializes products for musculoskeletal disorders. The company provides product such as neocart, a tissue implant produced using a patient's own cartilage cells which are harvested from non-weight-bearing cartilage surface of the patient's femur. It offers products which are used to repair knee cartilage damage. Histogenics provides regenerative medicine platform that combines bioadhesives, cell processing, scaffolding, tissue engineering and growth factors to provide solutions for cartilage injuries associated with bone loss and arthritis. It also offers a platform for tissue repair solutions. Histogenics is headquartered in Waltham, Massachusetts, the US.

Histogenics Corp (HSGX)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Products

Products

Histogenics Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Table of Contents

Table of Contents

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Histogenics Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Histogenics Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Histogenics Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Histogenics Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 8

Histogenics Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Histogenics Corp, Medical Equipment, Deal Details 10

Venture Financing 10

Histogenics Raises USD 10.3 Million In Venture Financing 10

Histogenics Raises USD 49 Million In Series A Financing 11

Partnerships 13

Medinet Enters into Licensing Agreement with Histogenics 13

Histogenics Enters into Licensing Agreement with Advanced BioMatrix 14

Histogenics Enters into Licensing Agreement with Koken 15

Equity Offering 16

Histogenics Raises USD17 Million in Public Offering of Shares and Warrants 16

Histogenics Plans to Raise USD75 Million in Public Offering of Securities 18

Histogenics Raises USD6.3 Million in Public Offering of Shares 19

Histogenics Files Registration Statement for Public Offering of Shares to Raise USD50 Million 20

Histogenics Raises USD30 Million in Private Placement of Shares, Series A Preferred Stock and Warrants 21

Histogenics Prices IPO for USD65 Million 22

Histogenics Corp-Key Competitors 24

Histogenics Corp-Key Employees 25

Histogenics Corp-Locations And Subsidiaries 26

Head Office 26

Other Locations & Subsidiaries 26

Recent Developments 27

Financial Announcements 27

Aug 09, 2018: Histogenics announces second quarter 2018 financial and operating results 27

May 10, 2018: Histogenics Announces First Quarter 2018 Financial and Operating Results 29

Mar 15, 2018: Histogenics Announces Financial and Operating Results for the Fourth Quarter and Year Ended December 31, 2017 30

Nov 09, 2017: Histogenics Announces Third Quarter 2017 Financial and Operating Results 33

Aug 10, 2017: Histogenics Announces Second Quarter 2017 Financial and Operating Results 34

May 11, 2017: Histogenics Announces First Quarter 2017 Financial and Operating Results 36

Mar 16, 2017: Histogenics Announces Financial and Operating Results for the Fourth Quarter and Year Ended December 31, 2016 37

Corporate Communications 39

Jul 31, 2018: Histogenics appoints E. Lynne Kelley, M.D., FACS as chief medical officer 39

Apr 18, 2018: Histogenics Appoints Susan Washer As Board Director 40

Oct 12, 2017: Histogenics Promotes Stephen Kennedy to Executive Vice President & Chief Operating Officer 41

Sep 18, 2017: Histogenics Announces Resignation of CMO 42

Jun 05, 2017: Histogenics Announces the Appointment of Donald Haut, Ph.D. as Chief Business Officer 43

May 15, 2017: Histogenics Receives Innovation Award 44

Appendix 45

Methodology 45

About GlobalData 45

Contact Us 45

Disclaimer 45


List of Figure

List of Figures

Histogenics Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Histogenics Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Histogenics Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Histogenics Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Histogenics Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Histogenics Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 6

Histogenics Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Histogenics Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 8


List of Table

List of Tables

Histogenics Corp, Medical Equipment, Key Facts, 2017 2

Histogenics Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Histogenics Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Histogenics Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Histogenics Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Histogenics Corp, Deals By Market, 2012 to YTD 2018 8

Histogenics Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Histogenics Raises USD 10.3 Million In Venture Financing 10

Histogenics Raises USD 49 Million In Series A Financing 11

Medinet Enters into Licensing Agreement with Histogenics 13

Histogenics Enters into Licensing Agreement with Advanced BioMatrix 14

Histogenics Enters into Licensing Agreement with Koken 15

Histogenics Raises USD17 Million in Public Offering of Shares and Warrants 16

Histogenics Plans to Raise USD75 Million in Public Offering of Securities 18

Histogenics Raises USD6.3 Million in Public Offering of Shares 19

Histogenics Files Registration Statement for Public Offering of Shares to Raise USD50 Million 20

Histogenics Raises USD30 Million in Private Placement of Shares, Series A Preferred Stock and Warrants 21

Histogenics Prices IPO for USD65 Million 22

Histogenics Corp, Key Competitors 24

Histogenics Corp, Key Employees 25

Histogenics Corp, Subsidiaries 26

You can also purchase parts of this report.
Do you want to check out a section wise price list?
Get Price Break-up

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022